SS19. Cyber Medicine Enables Remote Neuromonitoring during Aortic Surgery  by Greiner, Andreas et al.
(47.9% vs. 45.1%), and to have hypercholesterolemia (55.0%
vs. 51.5%) than women who had not used HRT (p .001).
However, they were less likely to have diabetes (8.6% vs.
10.1%, p .001). Despite the increased prevalence of several
atherosclerotic risk factors among women who used HRT,
they were significantly less likely to have PAD (3.3% vs. 4.1%,
p.001).Multivariate analysis confirmed thatHRTwas inde-
pendently associated with a decreased risk of PAD (OR 0.8,
95% CI 0.78-0.82). In postmenopausal women with existing
risk factors, the significant effect of HRT on the prevalence
PADwasmaintained: in postmenopausal womenwith either a
smoking history, hypertension, hypercholesterolemia, or dia-
betes, the odds ratio of HRT use with regard to PAD re-
mained 0.8.
Conclusions: The use of HRT in postmenopausal
women is associated with a significant reduction in the
prevalence of PAD. This association was significant even in
postmenopausal female patients with known atheroscle-
rotic risk factors. This data has important implications with
regard to a possible protective effect of HRT on atheroscle-
rotic conditions, particularly in patients at higher risk for
these conditions due to medical co-morbidities.
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donado: Nothing to disclose; T. S. Riles: Nothing to
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Objectives: The operative mortality of complicated type
B aortic dissection (CTBAD) is reported to be as high as
30%. The use of endografts in the treatment of CTBAD is
well described. However, significant questions still remain
on timing, patient selection, anatomical limitations, treat-
ment length and device performance. With these questions
in mind, the objective of this study was to evaluate the
safety and effectiveness of a unique composite (proximal
stent graft and distal bare metal stent) TEVAR construct in
the treatment of patients with CTBAD.
Methods: For this prospective, single-arm, interna-
tional study, patients with CTBAD were treated with a
combination of proximal endovascular thoracic grafts and
distal bare endovascular stents. Indications for enrollment
were malperfusion of visceral organs, impending rupture,
aortic diameter 4 cm, rapid aortic expansion, persistent
uncontrollable pain or hypertension despite maximum
medical therapy. Study endpoint was mortality at 30 days.
One year follow-up with scheduled clinical and radio-
graphic (CT and X-ray) were available.
Results: Ten centers enrolled 40 patients between
12/2007 and 9/2009. The majority of patients were male
(28,70%) and the mean age was 58 years. All patients had
multiple specific indications for treatment (31,77.5% im-
pending rupture/malperfusion), and the mean time
from presentation to treatment was 20 days (range
0-78). All devices were successfully deployed and patent.
The 30-day mortality rate was 5% (2). Thirty-day mor-
bidity included stroke (4,10%), paraplegia (1,2.5%), aor-
tic rupture (1,2.5%) and renal failure (5,12.5%). No pa-
tient became dialysis dependent. No conversions to open
surgery, issues with device integrity, or stentmigration have
been observed.
Conclusions: Initial data with a composite TEVAR
construct have demonstrated favorable clinical and ana-
tomic results. Continued enrollment and long-term data
are needed to assess the overall effectiveness of this treat-
ment strategy.
Author Disclosures: P. Bharadwaj: Med Institute, Em-
ployment (full or part-time); R. Cambria: Nothing to
disclose; R. Chiesa: Nothing to disclose; A. Lee: Nothing
to disclose; J. V. Lombardi: Cook Medical, Research
GrantsCook Medical, Honorarium; P. Mossop: Nothing
to disclose; C. A. Nienaber: Nothing to disclose;
O. Teebken: Nothing to disclose.
SS19.
Cyber Medicine Enables Remote Neuromonitoring
during Aortic Surgery
Andreas Greiner1, Werner H. Mess2, Jürgen Schmidli4,
Sebastian E. Debus5, Jochen Grommes1, F. Dick5, Michael
Jacobs3. 1European Vascular Center Aachen-Maastricht,
Department of Vascular Surgery, University Hospital
RWTH Aachen, Aachen, Germany; 2Department of Clin-
ical Neurophysiology, Maastricht, Netherlands; 3European
Vascular Center Aachen-Maastricht, Department of Sur-
gery,, Maastricht, Netherlands; 4Department of Cardiovas-
cular Surgery, Inselspital, and University of Bern, Bern,
Switzerland; 5Department of Vascular Medicine, Univer-
sity Heart Center Hamburg Eppendorf, Hamburg,
Germany
Objectives: Neuromonitoring of spinal function by de-
tecting motor evoked potentials (MEPs) during open repair
(OR) of thoracoabdominal aortic aneurysms (TAAA) is a
valid method to assess insufficient arterial supply to alpha
motor neurones. This method requires a complex tech-
nique and specific neurophysiological expertise. We dem-
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onstrate how four European vascular centers resort to one
technical infrastructure and neuromonitoring-expertise
during TAAA OR by internet connection.
Methods: In 2009 and 2010, 121 patients were treated
by TAAAORusing identical protocols, including distal aortic
perfusion. All neurophysiological data from two centers in
Germany, one in Switzerland and one in the Netherlands
were evaluated by a central neurophysiologists team in a
Dutch Medical Center. Online assessment of MEPs was
installed using internet with Virtual Private Network Tun-
nelling. We investigated the reliability, stability and robust-
ness of this telemedical system.
Results: MEPs were monitored in all patients without
technical problems. In 61 patients a significant drop in MEPs
was recorded, requiring immediate protective adjustments. In
30 patients, blood pressure management, reposition of cross-
clamps, blocking of intercostal arteries or rewarming restored
MEPs. All other cases required reattachment of spinal cord
supplying arteries. In 59 patients the protective strategies
correctedMEPs completely. In all cases the data communica-
tion was stabile enabling successful MEPs evaluation by the
neurophysiologist in the Netherlands.
Conclusions: Remote neuromonitoring of spinal cord
function during aortic surgery is feasible and reliable. It
allows centralization of expertise and saves individual cen-
ters to invest in complex technology. The value of moni-
toring MEPs was confirmed in different centers, resulting
in adequate neurological outcome following extensive aor-
tic procedures.
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Objectives: To determine if a physician modified en-
dovascular graft (PMEG) is a safe and effective method of
treating juxtarenal aortic aneurysms in patients considered
to be unsuitable for open surgical repair.
Methods: A prospective, consecutively enrolling,
non-randomized single institution evaluation of the
safety and efficacy of physician modification of a cur-
rently FDA-approved device (COOK Zenith Flex) to
preserve branch vessels when used in the treatment of
patients with elective, symptomatic or ruptured juxtare-
nal aortic aneurysms.
Results: 47 consecutive patients underwent fenes-
trated endovascular repair using PMEG over a three year
period. 38 patients (80%) were symptomatic or had rapid
aneurysm expansion. 85% of patients were ASA category III
or IV. 82 fenestrations were created for 58 renal arteries, 16
SMA’s, 3 celiacs and the rest accessory vessels. Mean follow
up was 103 days (range 62-442). Mean contrast usage and
fluoro time were 98cc and 48 min. There were six compli-
cations (12.7%). Three (6.4%) were access related and three
(6.4%) were procedure related and included one stroke,
one renal failure and one branch artery dissection. On
follow up, only 6 patients (12.8%) had endoleak. Operative
mortality was 0%. In hospital and 30-day mortality was 2%
with 1 patient expiring due to aspiration on the ward after
successful endovascular repair. Two patients died during
follow up; one at 58 days due to cessation of dialysis and
one at 485 days due to stent graft migration and occlusion
of the SMA. There were two deaths in the first year, one in
the second and zero in the most recent year of experience.
One patient with endoleak had aneurysm sac expansion at 1
year requiring secondary intervention.
Conclusions: PMEG is a safe and effective alternative
for treating patients with juxtarenal aneurysms who have no
other alternatives for repair. Longer term follow up is
needed to assess the durability of repair and potential for
device-related complications.
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Video Presentation
Staged Total Abdominal Debranching and TEVAR for
Thoracoabdominal Aneurysm
Richard L. McCann. Duke University Medical Center,
Durham, NC
Background: We present a video illustrating an op-
tional strategy for repair of thoracoabdominal aortic
aneurysm in patients who, because of anatomic or phys-
iologic reasons, are not good candidates for standard
open repair.
Technical Description: The video is of a 70 year old
patient who had rapid growth of a 5.8 cm visceral segment
aneurysm after 3 prior TAA/TAAA procedures. In the first
stage, total abdominal debranching was accomplished
through a midline laparotomy using a multibranched Dacron
graft (Vascutek). This graft was based on the left common iliac
artery and consists of a 14 mm trunk with appropriately sized
side limbs for the left renal, SMA, Celiac, and right renal
arteries and an integral 10 mm conduit which was buried in a
lower abdominal subcutaneous pocket. This access limb ob-
viates surgical vascular dissection during the delayed endovas-
cular stage and was easily exposed and thrombectomized to
provide access for the second stage performed 5 days later.
The TEVAR procedure required 3 overlapping and tapering
Talent (Medtronic) components to exclude the aneurysm.
Confirmation of aneurysm exclusion and branch graft patency
by subsequent CT angiogram will be shown. This patient
remains well 4 months post operatively. We have performed
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